Cargando…

Prophylactic anticoagulation with low dose enoxaparin: is the subcutaneous route appropriate in the critically ill?

Detalles Bibliográficos
Autores principales:	Priglinger, U, Delle Karth, G, Geppert, A, Joukhadar, C, Berger, R, Hülsmann, M, Pabinger, I, Heinz, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2002
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333540/ http://dx.doi.org/10.1186/cc1581

Ejemplares similares

Epidemiology of gender-related differences of arrhythmias in the ICU
por: Priglinger, U, et al.
Publicado: (2001)

A circadian pattern of occurrence of ventricular tachycardia and atrial fibrillation is present during periods of analgosedation
por: Heinz, G, et al.
Publicado: (2001)

Epidemiology of cardiac arrhythmias in a medical-cardiologic intensive care unit: single center experience
por: Heinz, G, et al.
Publicado: (2000)

Monitoring of cardiac output in cardiogenic shock and low-output heart failure: LiDCO vs pulmonary artery catheter thermodilution
por: Meyer, B, et al.
Publicado: (2006)

Subcutaneous Enoxaparin for Systemic Anticoagulation of COVID-19 Patients During Extracorporeal Life Support
por: Wiegele, Marion, et al.
Publicado: (2022)

Anti-Xa activities following 5,000 IU and 7,500 IU of s.c. dalteparin in critically ill patients and 5,000 IU in medical patients: a prospective randomized study
por: Heinz, GH, et al.
Publicado: (2013)

Pro-B-type natriuretic peptide predicts mortality in critically ill patients
por: Meyer, B, et al.
Publicado: (2005)

Critical illness polyneuropathy: incidence and risk factors
por: Meyer, B, et al.
Publicado: (2006)

The use of enoxaparin during coronary angioplasty: study of clinical security
por: Gomes de Sá, S, et al.
Publicado: (2003)

Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
por: Meyer, B, et al.
Publicado: (2004)

A Retrospective Comparative Cohort Study of Craniotomy and Prophylactic Enoxaparin Timing
por: Hallan, David R, et al.
Publicado: (2022)

Postintubation tracheal injuries in critically ill patients - proposal for an additional prophylactic approach
por: Vukcevic, Z
Publicado: (1997)

The Levels of Tissue Factor Pathway Inhibitor in Sepsis Patients Receiving Prophylactic Enoxaparin
por: Al Otair, Hadil A., et al.
Publicado: (2016)

Evaluation of prophylactic dosages of Enoxaparin in non-surgical elderly patients with renal impairment
por: Chamoun, Nibal, et al.
Publicado: (2019)

Immunotherapy – 2073. Therapeutic effect of mite allergen vaccines by subcutaneous route in allergic Cuban asthmatic patients
por: Almarales, Raúl Lázaro Castro, et al.
Publicado: (2013)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
por: Inchiosa, Mario A., et al.
Publicado: (2012)

The Role of Jinhuang Powder to Prevent Adverse Effects of Subcutaneous Injection of Enoxaparin Sodium
por: Zhang, Meng, et al.
Publicado: (2022)

Multiple Subcutaneous (18)F-FDG-avid Granulomas Due to Enoxaparin Injection
por: Erol Fenercioğlu, Özge, et al.
Publicado: (2022)

Pharmacokinetics of enoxaparin in COVID-19 critically ill patients
por: Zufferey, Paul Jacques, et al.
Publicado: (2021)

Comparative Studies on the Anticoagulant Profile of Branded Enoxaparin and a New Biosimilar Version
por: Qneibi, Dalia, et al.
Publicado: (2020)

Bioavailability of IgG Administered by the Subcutaneous Route
por: Berger, Melvin, et al.
Publicado: (2013)

Prophylactic Anticoagulation in Nephrotic Syndrome
por: Gerstein, Jonathon, et al.
Publicado: (2023)

Critically ill patients with edema and ascites may experience subtherapeutic anti-factor Xa levels following abdominal subcutaneous enoxaparin treatment
por: Tharanon, Vichapat, et al.
Publicado: (2022)

Effect of subcutaneous Enoxaparin injection duration on bruising size in acute coronary syndrome patients
por: Dehghani, Khadije, et al.
Publicado: (2014)

Reversal Activity and Toxicity of Heparin-Binding Copolymer after Subcutaneous Administration of Enoxaparin in Mice
por: Swieton, Justyna, et al.
Publicado: (2021)

Controlled prophylactic normothermia
por: Broessner, Gregor, et al.
Publicado: (2012)

Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia
por: Tacquard, Charles, et al.
Publicado: (2021)

Enoxaparin as an Anticoagulant in a Multipara with a Mechanical Mitral Valve: A Case Report
por: Lee, Yo Seb, et al.
Publicado: (2023)

Anti-activated factor × response to enoxaparin in critically ill patients
por: Einav, S, et al.
Publicado: (2009)

Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism
por: Abdulla, Aliya, et al.
Publicado: (2023)

Supratherapeutic anti-factor Xa levels in patients receiving prophylactic doses of enoxaparin: A case series
por: Pannucci, Christopher J., et al.
Publicado: (2016)

Factor Xa Levels in Patients Receiving Prophylactic Enoxaparin Sodium in the Intensive Care Unit of an Academic Hospital
por: Baloo, Mayank M, et al.
Publicado: (2021)

A Pilot Study of Home Treatment of Deep Vein Thrombosis With Subcutaneous Once-Daily Enoxaparin Plus Warfarin
por: Bishop, Beverly, et al.
Publicado: (2006)

Rectus sheath hematoma in patients receiving subcutaneous enoxaparin: A case series of five patients
por: Mendes, Diogo, et al.
Publicado: (2020)

EVALUATION OF THERAPEUTIC VS PROPHYLACTIC ANTICOAGULATION IN NONCRITICALLY ILL PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA
por: GHOSH, KULDEEP, et al.
Publicado: (2022)

Anticoagulant properties of enoxaparin 400 IU/mL–40 % ethanol catheter lock solution
por: Calvet, Laure, et al.
Publicado: (2015)

Fondaparinux versus Enoxaparin - Which is the Best Anticoagulant for Acute Coronary Syndrome? - Brazilian Registry Data
por: Soeiro, Alexandre de Matos, et al.
Publicado: (2016)

Subcutaneous hematomas from prophylactic heparin use
por: Koratala, Abhilash, et al.
Publicado: (2017)

The Impact of Continuous Veno-Venous Hemodiafiltration on the Efficacy of Administration of Prophylactic Doses of Enoxaparin: A Prospective Observational Study
por: Aszkiełowicz, Aleksander, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gt4d2l7m4rda8uiia7lb4h46k0